Stock Comparison

JNJ vs VMD

Johnson & Johnson vs Viemed Healthcare Inc

The Verdict

VMD takes this one.

JNJ

Johnson & Johnson

1.0

out of 10

Distressed

Winner

VMD

Viemed Healthcare Inc

9.1

out of 10

Hidden Gem

Head-to-Head

$557.1B

Market Cap

$358M

26.5

P/E Ratio

24.1

21.8%

Profit Margin

5.2%

26.3%

Return on Equity

10.7%

0.6

Debt-to-Equity

0.1

Conservative

Overall Risk

Moderate

1.0

DVR Score

9.1

The Deep Dive

JNJ1.0/10

Johnson & Johnson (JNJ) continues to demonstrate robust financial performance, with Q1 2026 results exceeding consensus on both revenue and adjusted EPS, reflecting nearly 10% YoY revenue growth. Its diversified healthcare portfolio provides significant market leadership and a wide economic moat, indicating stability and consistent profitability. However, its massive market capitalization of $555....

Full JNJ Analysis

VMD9.1/10

Viemed Healthcare Inc. continues to exhibit strong performance and strategic execution within the high-growth tech-enabled home respiratory and chronic care market. Q1 2026 results show impressive 28% YoY revenue growth and an improved gross margin. The company has no net debt and generates substantial, growing free cash flow ($36.3M TTM), supporting its active share repurchase program. Management...

Full VMD Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.